Product NDC: | 25010-710 |
Proprietary Name: | Syprine |
Non Proprietary Name: | trientine hydrochloride |
Active Ingredient(s): | 250 mg/1 & nbsp; trientine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25010-710 |
Labeler Name: | Aton Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019194 |
Marketing Category: | NDA |
Start Marketing Date: | 19851108 |
Package NDC: | 25010-710-15 |
Package Description: | 1 BOTTLE in 1 CARTON (25010-710-15) > 100 CAPSULE in 1 BOTTLE |
NDC Code | 25010-710-15 |
Proprietary Name | Syprine |
Package Description | 1 BOTTLE in 1 CARTON (25010-710-15) > 100 CAPSULE in 1 BOTTLE |
Product NDC | 25010-710 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | trientine hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19851108 |
Marketing Category Name | NDA |
Labeler Name | Aton Pharma, Inc. |
Substance Name | TRIENTINE HYDROCHLORIDE |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Metal Chelating Activity [MoA],Metal Chelator [EPC] |